A biotin-avidin-amplified indirect immunofluorescence method was used to demonstrate specific serum immunoglobulin M (IgM) antibodies in nephropathia epidemica, the Scandinavian type of hemorrhagic fever with renal syndrome. The antigen in the test was the cross-reacting agent of Korean hemorrhagic fever, Hantaan virus. Sixty-two serum samples from 15 patients with clinically typical nephropathia epidemica were analyzed. Eleven patients had specific IgM in one or more serum samples. The IgM could be demonstrated from day 2 up to day 37, and all patients had detectable specific IgM within 15 days after the onset of disease. In 49 control serum samples, no specific IgM could be detected, indicating a high specificity for the method. The findings demonstrate that the biotin-avidin-amplified immunofluorescence IgM assay is a useful tool in the diagnosis of early nephropathia epidemica disease.
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The causative agents of nephropathia epidemica (NE) and Korean hemorrhagic fever (KHF) are antigenically closely related. This relationship has been used to study the serological response in NE by the immunofluorescence method (3) (4) (5) (6) 9) . With this technique, specific cross-reactive anti-KHF/NE serum immunoglobulin G (IgG) antibodies were successfully demonstrated when cells infected with the causative agent of KHF (Hantaan virus) and lung sections from bank voles persistently infected with the NE virus were used as antigens. In contrast, no specific serum IgM was found when lung sections from bank voles persistently infected with the NE virus were used (2). However, when serum samples were fractionated by ultracentrifugation and KHF virus-infected cells were used as antigen, specific IgM to KHF/NE could be demonstrated (10) .
In this paper an IgM-specific method is described for the serological diagnosis of NE, consisting of an indirect fluorescent-antibody technique (IFAT) amplified by the biotinavidin system. A total of 62 serum samples were collected from 15 patients with NE (11 Vero E-6 cells (CRL 1586) obtained from the American Type Culture Collection were grown in 25-ml plastic flasks (Nunc, Roskilde, Denmark) in Eagle minimal essential medium supplemented with 10% fetal calf serum, 1% glutamine, 100 IU of penicillin G per ml, and 100 ,ug of streptomycin per ml. The medium and calf serum were purchased from Flow Laboratories, Glasgow, Scotland. Fluorescein-labeled rabbit anti-human IgG (F 202; Dakopatt, Copenhagen, Denmark), biotin-labeled goat anti-human IgM (Ba 3020; Vector Laboratories, Sunnyvale, Calif.), and fluorescein-labeled avidin D (A 2001; Vector) were used in the IFAT.
Hantaan virus was adsorbed to Vero E-6 cell cultures at room temperature for 2 h. After adsorption, the inoculum was diluted with growth medium and incubated for 7 days at 37°C in a 5% C02 atmosphere. The infected cells were then trypsinized and passaged into two new similar plastic flasks. Viral antigen was demonstrable in the cells by IFAT after five to seven passages. To increase the antigen yield, cultures were incubated for 12 days before the final harvest. The Hantaan virus-infected cells were then trypsinized, washed twice in phosphate-buffered saline (PBS), and seeded at an appropriate density, as judged by inspection with a light microscope, onto spot slide glasses. The slides were air dried, treated with 100% cold acetone (-20°C) for 10 min, and stored at -70°C until use.
The serum samples were screened for the presence of anti-KHF/NE IgG by IFAT (3, 5) . Briefly, sera diluted 1/20 in PBS were added to KHF spot slides and incubated for 30 min at 37°C in a moist chamber, followed by rinsing for Reciprocal anti-KHF/NE IgMtiter mixture was incubated for 25 min at room temperature and centrifuged at 2,300 x g for 10 min. The supernatants, containing sera diluted 1/40, were incubated on KHF spot slides overnight at 37°C in a moist chamber. After the slides were washed with PBS, biotin-labeled anti-human IgM (final dilution, 1/300) was added and incubated for 30 min at 37°C, followed by washing. Fluorescein-conjugated avidin (final dilution, 1/300) was then allowed to react on the slides for 5 min at room temperature. After a final wash, the slides were counterstained, rinsed in deionized water, and mounted. Serum samples that showed a positive reaction at the 1/40 dilution were endpoint titrated in twofold dilution steps. The slides were examined in a Leitz Ortholux II fluorescence microscope with a 10x ocular lens and a 40x objective lens. The endpoint was defined as the highest titer at which a bright cytoplasmatic, particulate fluorescence could be seen (Fig. 1) . Negative and positive control sera-were included in all experiments, and all sera were studied under code.
Of 15 patients, 11 had specific IgM to KHF/NE in one or more of their serum samples (Fig. 2) . In these 11 patients, the specific IgM was demonstrable within 15 days after the onset of disease and in one patient as early as 2 days after onset. Onset of disease was defined as the first day of fever. The maximal duration of detectable specific IgM was 5 weeks, and the highest IgM titer demonstrated was 1/320.
Four patients had no demonstrable specific IgM. All serum samples from these patients had been freeze-thawed three times or more. To determine whether this procedure had degraded preexisting IgM antibodies, three serum samples with high titers (1/160 to 1/320) were freeze-thawed repeatedly. After the first freeze-thaw, titers dropped to 1/80, and after the third freeze-thaw, no specific KHF NE IgM antibodies could be detected (data not shown). Anti-KHF/NE IgM or IgG antibodies were not detected in any of the 49 control serum samples.
The specific serum IgM response in NE has been little studied. In one study, in which lung sections from NE virus-infected bank voles (Clethrionomys glareolus) were used as antigen, no specific IgM could be demonstrated by 60 IFAT (2) . Traavik et al. (10) found, by using IFAT with the KHF virus as antigen, specific KHF/NE IgM in sera that had been obtained early and fractionated by sucrose density gradient centrifugation. All fractionated sera with demonstrable specific IgM were obtained less than 40 days after the onset of disease. Presumably, the levels of circulating specific IgM are low in NE. One reason for this could be the deposition of antibodies in immune complexes, as previously reported (7) . Sensitive methods are therefore needed for the detection of specific IgM. The successful demonstration of specific anti-KHF/NE IgM antibodies in 11 of our 15 patients could be explained by the following factors. First, the IFAT used was amplified by the biotin-avidin system, which has been reported to increase sensitivity at least five times (1) . The mechanism behind the amplifying effect of the biotin-avidin system is the extraordinarily high affinity between biotin and avidin (Kd = 10-'5), but it is also a result of the multiple binding sites of avidin for biotin (1, 11) . Second, sensitivity was increased by using a prolonged serum incubation period (overnight at 37°C). In a previous study (2) in which unfractionated sera were used, the incubation time was 3 h at room temperature. Third, rheumatoid factor formation often occurs in NE (7) . The interference of rheumatoid factors leads to nonspecific IgM positivity in the IFAT in the presence of specific IgG antibodies. This interference was eliminated in the present study by preadsorption of sera with latex RF reagent. Fourth, as expected, repeated freeze-thaws degraded the anti-KHF/NE IgM antibodies. The lack of demonstrable specific IgM in four of our patients could possibly have been due to such a process since all their serum samples had been freeze-thawed several times.
We found no specific anti-KHF/NE IgM antibodies in any of the 49 control serum samples, which indicates a high specificity for the IFAT-biotin-avidin system method. This has also been documented previously (1, 11) .
In conclusion, the biotin-avidin-amplified immunofluorescence technique is a sensitive and reliable method for the detection of specific serum IgM against KHF/NE, provided serum samples are not repeatedly freeze-thawed.
